DNTH

Dianthus Therapeutics, Inc. /DE/ SEC filings

Every EDGAR filing for Dianthus Therapeutics, Inc. /DE/ (DNTH), newest first, with AI summaries and stories.

Ticker
DNTH
CIK
1690585
Latest filing
Sep 18

Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Get an email when Dianthus Therapeutics, Inc. /DE/ files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

  10. 4Dianthus Therapeutics, Inc. /DE/DNTH

    3 insider filings

    Anne McGeorge, insider filing for DNTH

    Show all 3
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH

    Anne McGeorge, reporting

  11. 144Dianthus Therapeutics, Inc. /DE/DNTH

    3 Form 144 notices

    Adam M Veness, planned sale of DNTH shares

    Show all 3
    • 144Planned insider sale of DNTH shares
    • 144Planned insider sale of DNTH shares
    • 144Planned insider sale of DNTH shares

    Adam M Veness, reporting

  13. 144Dianthus Therapeutics, Inc. /DE/DNTH

    3 Form 144 notices

    Marino Garcia, planned sale of DNTH shares

    Show all 3
    • 144Planned insider sale of DNTH shares
    • 144Planned insider sale of DNTH shares
    • 144Planned insider sale of DNTH shares

    Marino Garcia, reporting

  14. SCHEDULE 13G/ADianthus Therapeutics, Inc. /DE/DNTH

    2 13G filings

    Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13GOwnership stake disclosure

    T. Rowe Price Investment Management, Inc., filed by

  25. 4Dianthus Therapeutics, Inc. /DE/DNTH

    7 insider filings

    Anne McGeorge, insider filing for DNTH

    Show all 7
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH
    • 4Insider filing for DNTH

    Anne McGeorge, reporting

  27. SCHEDULE 13G/ADianthus Therapeutics, Inc. /DE/DNTH

    2 13G filings

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

  28. SCHEDULE 13GDianthus Therapeutics, Inc. /DE/DNTH

    2 13G filings

    Ownership stake disclosure by Sirenia Capital Management LP

    Show all 2
    • SCHEDULE 13GOwnership stake disclosure
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    Sirenia Capital Management LP, filed by

Older filings on EDGAR